Systematic evidence analysis for the transition from relapsing to secondary progressive Multiple Sclerosis in adults

被引:0
|
作者
Badgujar, L. [1 ]
Khurana, V. [1 ]
Malepati, A. [1 ]
Meier, D. Piani [2 ]
Adlard, N. [2 ]
机构
[1] Novartis Healthcare Pvt Ltd, Hyderabad, Telangana, India
[2] Novartis Pharma AG, Basel, Switzerland
关键词
D O I
暂无
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
EPO1208
引用
收藏
页码:471 / 472
页数:2
相关论文
共 50 条
  • [31] Intracortical excitability in patients with relapsing-remitting and secondary progressive multiple sclerosis
    Conte, A.
    Lenzi, D.
    Frasca, V.
    Gilio, F.
    Giacomelli, E.
    Gabriele, M.
    Bettolo, C. Marini
    Iacovelli, E.
    Pantano, P.
    Pozzilli, C.
    Inghilleri, M.
    JOURNAL OF NEUROLOGY, 2009, 256 (06) : 933 - 938
  • [32] Comparative myelin water imaging in relapsing remitting and secondary progressive multiple sclerosis
    Koehler, C.
    Kuntke, P.
    Wahl, H.
    Fischer, S.
    Ziemssen, T.
    Linn, J.
    Kitzler, H. H.
    MULTIPLE SCLEROSIS JOURNAL, 2020, 26 (3_SUPPL) : 385 - 385
  • [33] Risk of transition to secondary progressive multiple sclerosis and accumulation of disability in progressive multiple sclerosis are not influenced by current therapies
    Alcala, C.
    Gascon, F.
    Perez-Miralles, F-C.
    Escutia, M.
    Coret, F.
    Casanova, B.
    MULTIPLE SCLEROSIS JOURNAL, 2017, 23 : 702 - 702
  • [34] Relapsing and progressive forms of multiple sclerosis: insights from pathology
    Dutta, Ranjan
    Trapp, Bruce D.
    CURRENT OPINION IN NEUROLOGY, 2014, 27 (03) : 271 - 278
  • [35] Systematic Review and Meta-Analysis Comparing the Safety of Natalizumab, Ocrelizumab, and Alemtuzumab in Treating Relapsing-Remitting, Primary Progressive, and Secondary Progressive Multiple Sclerosis
    Raina, Pooja
    Basu, Somnath
    Goyal, Ramesh K.
    Sahoo, Pravat K.
    Mathur, Rajani
    JOURNAL OF PHARMACOLOGY & PHARMACOTHERAPEUTICS, 2022, 13 (01) : 14 - 23
  • [36] Monitoring cognition in relapsing-remitting multiple sclerosis (RRMS) and secondary progressive multiple sclerosis (SPMS) patients
    White, J.
    Gabriele, S.
    Lin, D.
    Vindici, J.
    Teoh, S.
    MULTIPLE SCLEROSIS JOURNAL, 2021, 27 (2_SUPPL) : 214 - 214
  • [37] Managing the transition to secondary progressive multiple sclerosis: a scoping review
    Giordano, A.
    Koepke, S.
    Confalonieri, P.
    De Luca, G.
    Pietrolongo, E.
    Trojano, M.
    Tortorella, C.
    Borreani, C.
    Uccelli, M. Messmer
    Clerici, V. Torri
    Gitto, L.
    Giovannetti, A. M.
    Heesen, C.
    Solari, A.
    MULTIPLE SCLEROSIS JOURNAL, 2017, 23 : 957 - 958
  • [38] Diagnostic uncertainty during the transition to secondary progressive multiple sclerosis
    Sand, Ilana Katz
    Krieger, Stephen
    Farrell, Colleen
    Miller, Aaron E.
    MULTIPLE SCLEROSIS JOURNAL, 2014, 20 (12) : 1654 - 1657
  • [39] Diagnostic uncertainty during the transition to secondary progressive multiple sclerosis
    Sand, I. Katz
    Krieger, S.
    Farrell, C.
    Miller, A.
    MULTIPLE SCLEROSIS JOURNAL, 2012, 18 : 55 - 56
  • [40] Managing the transition to secondary progressive multiple sclerosis: a scoping review
    Giordano, Andrea
    Koepke, Sascha
    Confalonieri, Paolo
    Onofrj, Marco
    Pietrolongo, Erika
    Trojano, Maria
    Tortorella, Carla
    Borreani, Claudia
    Uccelli, Michele Messmer
    Gitto, Lara
    Giovannetti, Ambra Mara
    Solari, Alessandra
    MULTIPLE SCLEROSIS JOURNAL, 2017, 23 (06) : 912 - 913